Concepedia

Publication | Open Access

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

DOIFull Paper Access

6.8K

Citations

21

References

2020

Year

Richard S. Finn, Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae‐You Kim, Masatoshi Kudo, Philippe Merle, Ahmed O. Kaseb, Daneng Li,
New England Journal of Medicine

Abstract

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. (Funded by F. Hoffmann-La Roche/Genentech; ClinicalTrials.gov number, NCT03434379.).

References

YearCitations

Page 1